Brief: Iovance Biotherapeutics Says Pricing Of 23 Million Shares Of Its Common Stock At An Offering Price Of $9.15 Per Share
Feb 20 (Reuters) - Iovance Biotherapeutics Inc IOVA.O :
* IOVANCE BIOTHERAPEUTICS, INC. ANNOUNCES PRICING OF $211
MILLION
UNDERWRITTEN OFFERING OF COMMON STOCK
* IOVANCE BIOTHERAPEUTICS INC SAYS PRICING OF AN
UNDERWRITTEN
OFFERING OF 23 MILLION SHARES OF ITS COMMON STOCK AT AN OFFERING
PRICE OF $9.15 PER SHARE
Source text for Eikon: ID:nGNX2tgVby
Further company coverage: IOVA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies